Laboratory technician

Role Description

This is a full-time on-site laboratory technician position at MONCYTE Health in Helsinki. Part-time is also an option. The laboratory technician will be responsible for processing incoming patient samples and performing cellular assays. In addition, the technician will be responsible for laboratory organization, including ordering, inventory, regulatory and quality management.

Experience in cell culture routines and laboratory organization is required. The applicant should have an interest in new technologies and be open to learning something new every day. MONCYTE Health represents an international team and the working language is English.

The closing date for applications is: 17.09.2026

It is possible that decisions about filling the position are made before the final deadline. Applications will be shared internally with the evaluation team.

Qualifications

Laboratory Equipment and Laboratory Skills

Experience in cell culture work

Quality Control and Analytical Skills

Extensive experience working as a Laboratory Technician

Ability to work effectively in a team setting

Strong attention to detail and organization skills

Knowledge of laboratory safety procedures

#cellbiology #microscopy #cellculture

Company Description

MONCYTE Health, established in 2024, is an early-stage Finnish health technology company developing a novel solution that integrates cellular diagnostics with robotics, high-resolution imaging, advanced software, and AI. The focus of the solution is to uncover and analyze the cellular mechanisms driving inflammation within atherosclerotic plaque, a key factor in cardiovascular disease.

This multidisciplinary approach enables a level of biological insight that current diagnostic methods do not provide, and supports the development of more targeted, effective care pathways. The technology is designed to generate new, clinically relevant data that benefits not only physicians in determining cardiovascular and residual risk and tailoring treatment decisions but also pharmaceutical companies developing next-generation cardiovascular and inflammation-modulating therapies.